niclosamide has been researched along with Cells, Neoplasm Circulating in 3 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
Excerpt | Relevance | Reference |
---|---|---|
" Further, encapsulation of NCS improved its effectiveness in vitro, particularly against colonspheres, and allowed to increase its intravenous dosage in vivo by increasing the amount of NCS able to be administered without causing toxicity." | 5.62 | Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo. ( Abasolo, I; Andrade, F; Arango, D; Boullosa, A; Cámara-Sánchez, P; Díaz-Riascos, ZV; García-Aranda, N; Martínez-Trucharte, F; Montero, S; Nestor, M; Rafael, D; Sarmento, B; Schwartz, S; Seras-Franzoso, J; Vilar-Hernández, M, 2021) |
" Further, encapsulation of NCS improved its effectiveness in vitro, particularly against colonspheres, and allowed to increase its intravenous dosage in vivo by increasing the amount of NCS able to be administered without causing toxicity." | 1.62 | Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo. ( Abasolo, I; Andrade, F; Arango, D; Boullosa, A; Cámara-Sánchez, P; Díaz-Riascos, ZV; García-Aranda, N; Martínez-Trucharte, F; Montero, S; Nestor, M; Rafael, D; Sarmento, B; Schwartz, S; Seras-Franzoso, J; Vilar-Hernández, M, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hochmair, M | 1 |
Rath, B | 1 |
Klameth, L | 1 |
Ulsperger, E | 1 |
Weinlinger, C | 1 |
Fazekas, A | 1 |
Plangger, A | 1 |
Zeillinger, R | 1 |
Hamilton, G | 1 |
Hilfenhaus, G | 1 |
Mompeón, A | 1 |
Freshman, J | 1 |
Prajapati, DP | 1 |
Hernandez, G | 1 |
Freitas, VM | 1 |
Ma, F | 1 |
Langenbacher, AD | 1 |
Mirkov, S | 1 |
Song, D | 1 |
Cho, BK | 1 |
Goo, YA | 1 |
Pellegrini, M | 1 |
Chen, JN | 1 |
Damoiseaux, R | 1 |
Iruela-Arispe, ML | 1 |
Andrade, F | 1 |
Rafael, D | 1 |
Vilar-Hernández, M | 1 |
Montero, S | 1 |
Martínez-Trucharte, F | 1 |
Seras-Franzoso, J | 1 |
Díaz-Riascos, ZV | 1 |
Boullosa, A | 1 |
García-Aranda, N | 1 |
Cámara-Sánchez, P | 1 |
Arango, D | 1 |
Nestor, M | 1 |
Abasolo, I | 1 |
Sarmento, B | 1 |
Schwartz, S | 1 |
3 other studies available for niclosamide and Cells, Neoplasm Circulating
Article | Year |
---|---|
Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines.
Topics: Antigens, CD; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Humans; Lung Neop | 2020 |
A High-Content Screen Identifies Drugs That Restrict Tumor Cell Extravasation across the Endothelial Barrier.
Topics: Animals; Cell Communication; Cell Line, Tumor; Cell Proliferation; Colforsin; Drug Screening Assays, | 2021 |
Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo.
Topics: Cell Line, Tumor; Colorectal Neoplasms; Humans; Hyaluronan Receptors; Micelles; Neoplastic Cells, Ci | 2021 |